ISCHEMIC CARDIOMYOPATHY
Clinical trials for ISCHEMIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new ISCHEMIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for ISCHEMIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells aim to repair damaged hearts in first human trial
Disease control Not yet recruitingThis early-phase study tests whether a new type of cell therapy, called CAR-DC, is safe for people with severe heart failure due to blocked arteries. The therapy uses a patient's own immune cells, modified to target a protein called FAP that is linked to heart scarring. Fifteen a…
Matched conditions: ISCHEMIC CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New scan could reveal hidden nerve damage in failing hearts
Diagnosis Not yet recruitingThis study tests a new imaging agent called 18F-mFBG to see how well it can show nerve damage in the hearts of people with heart failure and an implantable defibrillator (ICD). About 20 adults with stable heart failure from blocked arteries will get a PET scan using this agent. T…
Matched conditions: ISCHEMIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) • Aim: Diagnosis
Last updated May 26, 2026 03:57 UTC